Charles River Laboratories Intl. Inc vs Seagate Technology Holdings PLC — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Seagate Technology Holdings PLC trades at $783 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 12.4× Charles River Laboratories Intl. Inc's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Seagate Technology Holdings PLC for 41 Days on average.
| CRL | STX | |
|---|---|---|
Market Cap | $14.23B | $176.19B |
Volume | 1,176,885 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $310.77 | $1.09K |
52-Week Low | $149.93 | $211.63 |
Typical Hold Time | 33 Days | 41 Days |
Enterprise Value | $17.06B | $178.34B |
Dividend Yield | — | 0.38% |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
Seagate Technology (STX) trades at $774.83, down 4.03% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10 estimate, and robust profitability metrics including 26.11% net margin and 371.53% ROE. Technical indicators signal bearish momentum with the price below key resistance levels, while analyst consensus remains positive with 53.85% buy ratings and $1,130 price target.
Despite near-term competitive pressures, Seagate maintains strong positioning in AI storage markets with projected 2026 revenue growth to $12.2B. The primary risk involves Toshiba's capacity expansion potentially eroding pricing power. Current valuation multiples appear elevated (P/E 55.74, P/S 14.55) but are supported by exceptional profitability and AI-driven demand outlook.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →